Bracing For The Cold: Time For Korean Bioventures To Cut Down

Select And Focus Strategy Recommended

Gi Soo Kang, Partner, BNH Investment
Korean Firms Should Consider Various Funding Options
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia